The present invention provides compounds of Formula (I): (I) or stereoisomers tautomers or pharmaceutically acceptable salts thereof wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular smooth muscle oncologic neuropathologic autoimmune fibrotic and/or inflammatory disorders using the same.